Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Vaccines

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 254 articles:
HTML format
Text format



Single Articles


    October 2019
  1. HEALY SA, Murphy SC, Hume JCC, Shelton L, et al
    Chemoprophylaxis vaccination: Phase 1 study to explore stage-specific immunity to Plasmodium falciparum in U.S. adults.
    Clin Infect Dis. 2019 Oct 17. pii: 5588862. doi: 10.1093/cid/ciz1010.
    PubMed     Text format     Abstract available


  2. GOMES-SOLECKI M, Arnaboldi PM, Backenson PB, Benach JL, et al
    Protective Immunity and New Vaccines for Lyme Disease.
    Clin Infect Dis. 2019 Oct 17. pii: 5588349. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. LEVIN MJ, Weinberg A
    Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine.
    Clin Infect Dis. 2019 Oct 16. pii: 5588657. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. MEIRING JE, Giubilini A, Savulescu J, Pitzer VE, et al
    Generating the Evidence for Typhoid Vaccine Introduction: Considerations for Global Disease Burden Estimates and Vaccine Testing Through Human Challenge.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  5. CAREY ME, Diaz ZI, Broadstock M, Bailey R, et al
    Toward Control? The Prospects and Challenges of Typhoid Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  6. GOUMA S, Zost SJ, Parkhouse K, Branche A, et al
    Comparison of human H3N2 antibody responses elicited by egg-based, cell-based, and recombinant protein-based influenza vaccines during the 2017-2018 season.
    Clin Infect Dis. 2019 Oct 9. pii: 5584829. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. BATE J, Borrow R, Chisholm J, Clark S, et al
    13-valent Pneumococcal Conjugate Vaccine in children with acute lymphoblastic leukaemia: protective immunity can be achieved on completion of treatment.
    Clin Infect Dis. 2019 Oct 5. pii: 5581576. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2019
  8. DHAR N, Kwatra G, Nunes MC, Cutland C, et al
    Hemagglutinin-stalk antibody responses following trivalent inactivated influenza vaccine immunization of pregnant women and association with protection from influenza virus illness.
    Clin Infect Dis. 2019 Sep 27. pii: 5575323. doi: 10.1093.
    PubMed     Text format     Abstract available


  9. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    PubMed     Text format     Abstract available


  10. OTIENO GP, Bottomley C, Khagayi S, Adetifa I, et al
    Impact of the introduction of rotavirus vaccine on hospital admissions for diarrhoea among children in Kenya: A controlled interrupted time series analysis.
    Clin Infect Dis. 2019 Sep 23. pii: 5572563. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. STEELE AD, Groome MJ
    Measuring Rotavirus Vaccine Impact in sub-Saharan Africa.
    Clin Infect Dis. 2019 Sep 23. pii: 5572561. doi: 10.1093.
    PubMed     Text format    


  12. DONKEN R, Dobson SRM, Marty KD, Cook D, et al
    Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.
    Clin Infect Dis. 2019 Sep 6. pii: 5564371. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. KOURNA HAMA M, Khan D, Laouali B, Okoi C, et al
    Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  14. SONKO MA, Dube FS, Okoi CB, Diop A, et al
    Changes in the Molecular Epidemiology of Pediatric Bacterial Meningitis in Senegal After Pneumococcal Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  15. SANNEH B, Okoi C, Grey-Johnson M, Bah-Camara H, et al
    Declining Trends of Pneumococcal Meningitis in Gambian Children After the Introduction of Pneumococcal Conjugate Vaccines.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  16. BOULA A, Senghore M, Ngoh R, Tassadjo F, et al
    Hospital-based Surveillance Provides Insights Into the Etiology of Pediatric Bacterial Meningitis in Yaounde, Cameroon, in the Post-Vaccine Era.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  17. ANDRIATAHIRINTSOA EJPR, Raboba JL, Rahajamanana VL, Rakotozanany AL, et al
    Impact of 10-Valent Pneumococcal Conjugate Vaccine on Bacterial Meningitis in Madagascar.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  18. DONDO V, Mujuru H, Nathoo K, Jacha V, et al
    Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years-Zimbabwe, 2010-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  19. AGOSSOU J, Ebruke C, Noudamadjo A, Adedemy JD, et al
    Declines in Pediatric Bacterial Meningitis in the Republic of Benin Following Introduction of Pneumococcal Conjugate Vaccine: Epidemiological and Etiological Findings, 2011-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  20. MWENDA JM, Soda E, Weldegebriel G, Katsande R, et al
    Pediatric Bacterial Meningitis Surveillance in the World Health Organization African Region Using the Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2011-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  21. MPABALWANI EM, Lukwesa-Musyani C, Imamba A, Nakazwe R, et al
    Declines in Pneumonia and Meningitis Hospitalizations in Children Under 5 Years of Age After Introduction of 10-Valent Pneumococcal Conjugate Vaccine in Zambia, 2010-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  22. TAGBO BN, Bancroft RE, Fajolu I, Abdulkadir MB, et al
    Pediatric Bacterial Meningitis Surveillance in Nigeria From 2010 to 2016, Prior to and During the Phased Introduction of the 10-Valent Pneumococcal Conjugate Vaccine.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  23. FAYE PM, Sonko MA, Diop A, Thiongane A, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Meningitis and Pneumonia Hospitalizations in Children aged <5 Years in Senegal, 2010-2016.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  24. BONI-CISSE C, Jarju S, Bancroft RE, Lepri NA, et al
    Etiology of Bacterial Meningitis Among Children <5 Years Old in Cote d'Ivoire: Findings of Hospital-based Surveillance Before and After Pneumococcal Conjugate Vaccine Introduction.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


  25. RENNER LA, Usuf E, Mohammed NI, Ansong D, et al
    Hospital-based Surveillance for Pediatric Bacterial Meningitis in the Era of the 13-Valent Pneumococcal Conjugate Vaccine in Ghana.
    Clin Infect Dis. 2019;69.
    PubMed     Text format     Abstract available


    August 2019
  26. CASTELLI F
    Waiting for the malaria vaccine. The complex epidemiological transition towards malaria elimination.
    Clin Infect Dis. 2019 Aug 27. pii: 5555349. doi: 10.1093.
    PubMed     Text format    


  27. LIU B, He WQ, Newall AT, Quinn HE, et al
    Effectiveness of acellular pertussis vaccine in older adults: nested matched case-control study.
    Clin Infect Dis. 2019 Aug 26. pii: 5554689. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. AKECH S, Chepkirui M, Ogero M, Agweyu A, et al
    The clinical profile of severe paediatric malaria in an area targeted for routine RTS,S/AS01 malaria vaccination in Western Kenya.
    Clin Infect Dis. 2019 Aug 26. pii: 5554744. doi: 10.1093.
    PubMed     Text format     Abstract available


  29. CROWCROFT NS
    Pertussis vaccine is only modestly effective in adults: Another piece in the pertussis puzzle.
    Clin Infect Dis. 2019 Aug 26. pii: 5554663. doi: 10.1093.
    PubMed     Text format    


  30. CHENG MP, Quach C, Marty FM
    Herpes Zoster Subunit Vaccination for Renal Transplant Recipients.
    Clin Infect Dis. 2019 Aug 24. pii: 5554150. doi: 10.1093.
    PubMed     Text format    


  31. WANLAPAKORN N, Maertens K, Vongpunsawad S, Peunpa J, et al
    Quantity and quality of antibodies after acellular versus whole cell pertussis vaccines in infants born to mothers who received Tdap during pregnancy: a randomised trial.
    Clin Infect Dis. 2019 Aug 16. pii: 5550660. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. LINDSEY BB, Hoschler K, de Silva TI
    Complexities in predicting the immunogenicity of live attenuated influenza vaccines.
    Clin Infect Dis. 2019 Aug 14. pii: 5549953. doi: 10.1093.
    PubMed     Text format    


  33. MONTO AS
    Effectiveness of the live attenuated influenza vaccine: was additional of the second type B lineage a step too far?
    Clin Infect Dis. 2019 Aug 13. pii: 5549602. doi: 10.1093.
    PubMed     Text format    


  34. WEINBERGER DM, Shapiro ED
    Pneumococcal Vaccines for Adults: What's Next?
    Clin Infect Dis. 2019 Aug 12. pii: 5546063. doi: 10.1093.
    PubMed     Text format    


  35. AHMED SS, Pondo T, Xing W, McGee L, et al
    Early Impact of 13-valent Pneumococcal Conjugate Vaccine Use on Invasive Pneumococcal Disease among Adults with and without Underlying Medical Conditions-United States.
    Clin Infect Dis. 2019 Aug 12. pii: 5546062. doi: 10.1093.
    PubMed     Text format     Abstract available


  36. GOUMA S, Weirick M, Hensley SE
    Potential antigenic mismatch of the H3N2 component of the 2019 Southern Hemisphere influenza vaccine.
    Clin Infect Dis. 2019 Aug 11. pii: 5546015. doi: 10.1093.
    PubMed     Text format     Abstract available


  37. LEROUX-ROELS G, Bebia Z, Maes C, Aerssens A, et al
    Safety and immunogenicity of a second dose of an investigational maternal trivalent Group B streptococcus vaccine in non-pregnant women 4-6 years after a first dose: results from a phase 2 trial.
    Clin Infect Dis. 2019 Aug 8. pii: 5545276. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. MEDER KN, Jayasinghe S, Beard F, Dey A, et al
    Long-term impact of pneumococcal conjugate vaccines on invasive disease and pneumonia hospitalisations in Indigenous and non-Indigenous Australians.
    Clin Infect Dis. 2019 Aug 7. pii: 5544590. doi: 10.1093.
    PubMed     Text format     Abstract available


  39. WIESE AD, Grijalva CG
    To boost or not to boost? Lessons from the Australian pneumococcal conjugate vaccination program.
    Clin Infect Dis. 2019 Aug 7. pii: 5544622. doi: 10.1093.
    PubMed     Text format    


    July 2019
  40. RAY GT, Lewis N, Klein NP, Daley MF, et al
    Depletion of Susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2019 Jul 28. pii: 5540005. doi: 10.1093.
    PubMed     Text format     Abstract available


  41. HUGHES MM, Reed C, Flannery B, Garg S, et al
    Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden - United States.
    Clin Infect Dis. 2019 Jul 25. pii: 5538868. doi: 10.1093.
    PubMed     Text format     Abstract available


  42. CICCONI P, Jones C, Sarkar E, Reyes LS, et al
    First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.
    Clin Infect Dis. 2019 Jul 24. pii: 5537685. doi: 10.1093.
    PubMed     Text format     Abstract available


  43. KORSTEN K, Bont LJ
    Sustained cellular and humoral immune responses from an adenoviral vector-based RSV vaccine.
    Clin Infect Dis. 2019 Jul 24. pii: 5537713. doi: 10.1093.
    PubMed     Text format    


  44. KHAGAYI S, Omore R, Otieno GP, Ogwel B, et al
    Effectiveness of monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in Kenyan children.
    Clin Infect Dis. 2019 Jul 20. pii: 5536640. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. OEHLER RL
    On Measles, Vaccination, Social Media Activism and How to Win Back Our Role as our Patients' Best Advocates.
    Clin Infect Dis. 2019 Jul 15. pii: 5532609. doi: 10.1093.
    PubMed     Text format     Abstract available


  46. MISCHLINGER J, Muranaka R, Buhler S, Ramharter M, et al
    Measles, vaccines and types of perception bias in public debates.
    Clin Infect Dis. 2019 Jul 12. pii: 5531659. doi: 10.1093.
    PubMed     Text format    


    June 2019
  47. FERDINANDS JM, Alyanak E, Reed C, Fry AM, et al
    Waning of influenza vaccine protection: Exploring the trade-offs of changes in vaccination timing among older adults.
    Clin Infect Dis. 2019 Jun 29. pii: 5525379. doi: 10.1093.
    PubMed     Text format     Abstract available


  48. KLEIN NP, Fireman B
    If Influenza Vaccines Wane Can We Delay Vaccination Without Compromising Coverage?
    Clin Infect Dis. 2019 Jun 29. pii: 5525380. doi: 10.1093.
    PubMed     Text format    


  49. YAN D, Wang D, Zhu S, Zhang Y, et al
    Immunogenicity of oral polio vaccine and Salk inactive polio vaccine against Xinjiang imported type 1 wild poliovirus.
    Clin Infect Dis. 2019 Jun 25. pii: 5523198. doi: 10.1093.
    PubMed     Text format     Abstract available


  50. BLYTH CC, Jayasinghe S, Andrews RM
    A rationale for change: an increase in Invasive Pneumococcal Disease in fully vaccinated children.
    Clin Infect Dis. 2019 Jun 18. pii: 5519836. doi: 10.1093.
    PubMed     Text format     Abstract available


  51. GROENEVELD GH, Wijn DH, Vollaard AM
    Immune related adverse events in cancer patients receiving influenza vaccination and immune checkpoint inhibitors.
    Clin Infect Dis. 2019 Jun 17. pii: 5519876. doi: 10.1093.
    PubMed     Text format    


  52. TURNER P, Leab P, Ly S, Sao S, et al
    Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonisation and Invasive Disease in Cambodian Children.
    Clin Infect Dis. 2019 Jun 7. pii: 5512979. doi: 10.1093.
    PubMed     Text format     Abstract available


  53. MURDOCH DR
    Assessing the Impact of Pneumococcal Conjugate Vaccines.
    Clin Infect Dis. 2019 Jun 7. pii: 5512963. doi: 10.1093.
    PubMed     Text format    


  54. LIN KY, Sun HY, Chen YH, Lo YC, et al
    Effect of a hepatitis A vaccination campaign during a hepatitis A outbreak in Taiwan, 2015-2017: a modeling study.
    Clin Infect Dis. 2019 Jun 3. pii: 5510337. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2019
  55. GROOME MJ, Tate JE, Arnold M, Chitnis M, et al
    Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa.
    Clin Infect Dis. 2019 May 24. pii: 5498228. doi: 10.1093.
    PubMed     Text format     Abstract available


  56. KITCHIN N, Remich SA, Peterson J, Peng Y, et al
    A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years.
    Clin Infect Dis. 2019 May 24. pii: 5498282. doi: 10.1093.
    PubMed     Text format     Abstract available



  57. Preliminary Assessment of the Efficacy of a T-Cell-Based Influenza Vaccine, MVA-NP+M1, in Humans.
    Clin Infect Dis. 2019 May 23. pii: 5497806. doi: 10.1093.
    PubMed     Text format    


  58. MONTO AS, Petrie JG
    Improving influenza vaccine effectiveness: ways to begin solving the problem.
    Clin Infect Dis. 2019 May 17. pii: 5491466. doi: 10.1093.
    PubMed     Text format    


  59. BELONGIA EA, McLean HQ
    Influenza Vaccine Effectiveness: Defining the H3N2 Problem.
    Clin Infect Dis. 2019 May 17. pii: 5491465. doi: 10.1093.
    PubMed     Text format     Abstract available


  60. CHAGUZA C, Heinsbroek E, Gladstone RA, Tafatatha T, et al
    Early signals of vaccine driven perturbation seen in pneumococcal carriage population genomic data.
    Clin Infect Dis. 2019 May 16. pii: 5490137. doi: 10.1093.
    PubMed     Text format     Abstract available


  61. JALLOW S, Wilmshurst JM, Howard W, Copelyn J, et al
    Accelerated immunodeficiency-associated vaccine derived poliovirus serotype 3 (iVDPV3) sequence evolution rate in a 3-month old boy with X-linked agammaglobulinemia and perinatal HIV exposure.
    Clin Infect Dis. 2019 May 14. pii: 5489041. doi: 10.1093.
    PubMed     Text format     Abstract available


  62. CARVALHO CFA, Andrews N, Dabrera G, Ribeiro S, et al
    National Outbreak of Pertussis in England, 2011-2012: A Case-control Study Comparing 3-Component and 5-Component Acellular Vaccines With Whole-cell Pertussis Vaccines.
    Clin Infect Dis. 2019 May 6. pii: 5486166. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. SKOWRONSKI DM, De Serres G
    Evidence in a cluster randomized controlled trial of increased 2009 pandemic risk associated with 2008-09 seasonal influenza vaccine receipt.
    Clin Infect Dis. 2019 May 6. pii: 5485848. doi: 10.1093.
    PubMed     Text format    


  64. MATRAJT L, Halloran ME, Antia R
    Successes and failures of the live-attenuated influenza vaccine: can we do better?
    Clin Infect Dis. 2019 May 6. pii: 5485903. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2019
  65. WOLFSON LJ, Daniels VJ, Altland A, Black W, et al
    The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991-2016.
    Clin Infect Dis. 2019 Apr 24. pii: 5477436. doi: 10.1093.
    PubMed     Text format     Abstract available


  66. KOBAYASHI M, Bigogo G, Kim L, Mogeni OD, et al
    Impact of 10-valent Pneumococcal Conjugate Vaccine Introduction on Pneumococcal Carriage and Antibiotic Susceptibility Patterns among Children aged <5 Years and Adults with HIV Infection, Kenya 2009-2013.
    Clin Infect Dis. 2019 Apr 9. pii: 5432315. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. LINDHOLM DA, Fisher RD, Montgomery JR, Davidson W, et al
    Preemptive Tecovirimat Use in an Active Duty Member Presenting with Acute Myeloid Leukemia after Smallpox Vaccination.
    Clin Infect Dis. 2019 Apr 9. pii: 5432316. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. STEENS A, Winje BA, White RA, Odsbu I, et al
    Indirect Effects of Pneumococcal Childhood Vaccination in Individuals Treated With Immunosuppressive Drugs in Ambulatory Care: A Case-cohort Study.
    Clin Infect Dis. 2019;68:1367-1373.
    PubMed     Text format     Abstract available


  69. KELLNER JD
    Who Benefits, and How Much? Indirect Effects of Childhood Pneumococcal Vaccination in Adults at Increased Risk of Pneumococcal Disease.
    Clin Infect Dis. 2019;68:1374-1375.
    PubMed     Text format    


  70. MEMOLI MJ, Han A, Walters KA, Czajkowski L, et al
    Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.
    Clin Infect Dis. 2019 Apr 6. pii: 5429562. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. HARRIMAN K, Healy CM
    How Important Is the Type of Acellular Pertussis Vaccine?
    Clin Infect Dis. 2019 Apr 5. pii: 5486164. doi: 10.1093.
    PubMed     Text format    


    March 2019
  72. LE ROUX DM, Nicol MP, Myer L, Vanker A, et al
    Lower Respiratory Tract Infections in Children in a Well-vaccinated South African Birth Cohort: Spectrum of Disease and Risk Factors.
    Clin Infect Dis. 2019 Mar 29. pii: 5423418. doi: 10.1093.
    PubMed     Text format     Abstract available


  73. LU CY, Chiang CS, Chiu CH, Wang ET, et al
    Successful Control of Streptococcus pneumoniae 19A Replacement With a Catch-up Primary Vaccination Program in Taiwan.
    Clin Infect Dis. 2019 Mar 28. pii: 5421736. doi: 10.1093/cid/ciy1127.
    PubMed     Text format     Abstract available


  74. BLOK BA, de Bree LCJ, Diavatopoulos DA, Langereis JD, et al
    INTERACTING NON-SPECIFIC IMMUNOLOGICAL EFFECTS OF BCG AND Tdapf VACCINATIONS: AN EXPLORATIVE RANDOMIZED TRIAL.
    Clin Infect Dis. 2019 Mar 28. pii: 5421296. doi: 10.1093.
    PubMed     Text format     Abstract available


  75. VAN AALST M, Garrido HMG, van der Leun J, Meek B, et al
    Immunogenicity of the currently recommended pneumococcal vaccination schedule in patients with inflammatory bowel disease.
    Clin Infect Dis. 2019 Mar 22. pii: 5418537. doi: 10.1093.
    PubMed     Text format     Abstract available


  76. VERDOODT F, Dehlendorff C, Kjaer SK
    Dose-related effectiveness of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia: A Danish nationwide cohort study.
    Clin Infect Dis. 2019 Mar 20. pii: 5403490. doi: 10.1093.
    PubMed     Text format     Abstract available


  77. ROMANIN V, Acosta AM, Juarez MDV, Briere E, et al
    Maternal Vaccination in Argentina: Tdap Vaccine Effectiveness During Pregnancy in Preventing Pertussis in Infants Less Than 2 Months of Age.
    Clin Infect Dis. 2019 Mar 16. pii: 5381906. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. CHONG CR, Park VJ, Cohen B, Postow MA, et al
    Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors (ICI).
    Clin Infect Dis. 2019 Mar 15. pii: 5381697. doi: 10.1093.
    PubMed     Text format     Abstract available


  79. LEVY C, Varon E, Ouldali N, Bechet S, et al
    Changes in invasive pneumococcal disease spectrum after 13 valent pneumococcal conjugate vaccine implementation.
    Clin Infect Dis. 2019 Mar 14. pii: 5380638. doi: 10.1093.
    PubMed     Text format     Abstract available


  80. COLIN-JONES R, Shakya M, Voysey M, Theiss-Nyland K, et al
    Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  81. LUTHRA K, Watts E, Debellut F, Pecenka C, et al
    A Review of the Economic Evidence of Typhoid Fever and Typhoid Vaccines.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  82. THEISS-NYLAND K, Qadri F, Colin-Jones R, Zaman K, et al
    Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infection Among Bangladeshi Children: A Protocol for a Phase IIIb Trial.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  83. LAURENS MB, Sirima SB, Rotrosen ET, Siribie M, et al
    A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  84. THEISS-NYLAND K, Shakya M, Colin-Jones R, Voysey M, et al
    Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  85. JAMKA LP, Simiyu KW, Bentsi-Enchill AD, Mwisongo AJ, et al
    Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  86. LIU X, Pitzer VE, Pollard AJ, Voysey M, et al
    The Design and Analysis of Seroefficacy Studies for Typhoid Conjugate Vaccines.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  87. SAHA S, Islam MS, Sajib MSI, Saha S, et al
    Epidemiology of Typhoid and Paratyphoid: Implications for Vaccine Policy.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  88. KAUFHOLD S, Yaesoubi R, Pitzer VE
    Predicting the Impact of Typhoid Conjugate Vaccines on Antimicrobial Resistance.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  89. MEIRING JE, Sambakunsi R, Moyo E, Misiri T, et al
    Community Engagement Before Initiation of Typhoid Conjugate Vaccine Trial in Schools in Two Urban Townships in Blantyre, Malawi: Experience and Lessons.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  90. DEBELLUT F, Hendrix N, Pitzer VE, Neuzil KM, et al
    Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  91. MEIRING JE, Laurens MB, Patel P, Patel P, et al
    Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  92. VINK P, Ramon Torrell JM, Sanchez Fructuoso A, Kim SJ, et al
    Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: a Phase III, Randomized Clinical Trial.
    Clin Infect Dis. 2019 Mar 7. pii: 5370445. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. MILLER G
    Vaccine Prevention of Herpes Zoster in Organ Transplant Recipients: A Busy Intersection of Immune Responses to Foreign Antigens.
    Clin Infect Dis. 2019 Mar 7. pii: 5370442. doi: 10.1093.
    PubMed     Text format    


  94. HANSSON K, Rosdahl A, Insulander M, Vene S, et al
    Tick-borne encephalitis (TBE) vaccine failures: A ten-year retrospective study supporting the rationale for adding an extra priming dose in individuals from the age of 50 years.
    Clin Infect Dis. 2019 Mar 7. pii: 5370446. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2019
  95. MOSCICKI AB, Karalius B, Tassiopoulos K, Yao TJ, et al
    Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.
    Clin Infect Dis. 2019 Feb 21. pii: 5423927. doi: 10.1093/cid/ciy1040.
    PubMed     Text format     Abstract available


  96. HEFELE L, Syphan S, Xayavong D, Homsana A, et al
    Seroprotection at different levels of the health care system after routine vaccination with DTPw-HepB-Hib in Lao PDR.
    Clin Infect Dis. 2019 Feb 19. pii: 5335760. doi: 10.1093.
    PubMed     Text format     Abstract available


  97. CHURCH JA, Rukobo S, Govha M, Lee B, et al
    The impact of improved water, sanitation and hygiene on oral rotavirus vaccine immunogenicity in Zimbabwean infants: sub-study of a cluster-randomized trial.
    Clin Infect Dis. 2019 Feb 16. pii: 5321771. doi: 10.1093.
    PubMed     Text format     Abstract available


  98. WIESE AD, Huang X, Yu C, Mitchel EF, et al
    Changes in otitis media episodes and pressure equalization tube insertions among young children following introduction of the 13-valent pneumococcal conjugate vaccine: A birth-cohort based study.
    Clin Infect Dis. 2019 Feb 16. pii: 5321113. doi: 10.1093.
    PubMed     Text format     Abstract available


  99. BIGOGO GM, Audi A, Auko J, Aol GO, et al
    Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western Kenya.
    Clin Infect Dis. 2019 Feb 16. pii: 5346100. doi: 10.1093.
    PubMed     Text format     Abstract available


  100. NEUZIL KM, Pollard AJ, Marfin AA
    Introduction of Typhoid Conjugate Vaccines in Africa and Asia.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  101. KARIUKI S, Mbae C, Onsare R, Kavai SM, et al
    Multidrug-resistant Nontyphoidal Salmonella Hotspots as Targets for Vaccine Use in Management of Infections in Endemic Settings.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  102. YOUSAFZAI MT, Qamar FN, Shakoor S, Saleem K, et al
    Ceftriaxone-resistant Salmonella Typhi Outbreak in Hyderabad City of Sindh, Pakistan: High Time for the Introduction of Typhoid Conjugate Vaccine.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  103. SAHASTRABUDDHE S, Saluja T
    Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  104. BENTSI-ENCHILL AD, Hombach J
    Revised Global Typhoid Vaccination Policy.
    Clin Infect Dis. 2019;68.
    PubMed     Text format     Abstract available


  105. STEELE AD, Parashar UD
    Rotavirus Vaccines set to make inroads in Asia.
    Clin Infect Dis. 2019 Feb 13. pii: 5316811. doi: 10.1093.
    PubMed     Text format    


  106. SCHWARTZ LM, Zaman K, Yunus M, Basunia AH, et al
    Impact of rotavirus vaccine introduction in children less than 2 years of age presenting for medical care with diarrhea in rural Matlab, Bangladesh.
    Clin Infect Dis. 2019 Feb 12. pii: 5316286. doi: 10.1093.
    PubMed     Text format     Abstract available


  107. DESTEFANO F, Bodenstab HM, Offit PA
    Principal Controversies in Vaccine Safety in the United States.
    Clin Infect Dis. 2019 Feb 12. pii: 5316263. doi: 10.1093.
    PubMed     Text format     Abstract available


  108. SEGALOFF HE, Leventer-Roberts M, Riesel D, Malosh RE, et al
    Influenza Vaccine Effectiveness Against Hospitalization in Fully and Partially Vaccinated Children in Israel; 2015-16, 2016-17, and 2017-18.
    Clin Infect Dis. 2019 Feb 11. pii: 5314854. doi: 10.1093.
    PubMed     Text format     Abstract available


  109. SKOWRONSKI DM, De Serres G, Orenstein WA
    Caution required in the use of administrative data and general laboratory submissions for influenza vaccine effectiveness estimation.
    Clin Infect Dis. 2019 Feb 7. pii: 5308623. doi: 10.1093.
    PubMed     Text format    


  110. ROLFES MA, Flannery B, Chung J, O'Halloran A, et al
    Effects of Influenza Vaccination in the United States during the 2017-2018 Influenza Season.
    Clin Infect Dis. 2019 Feb 2. pii: 5305915. doi: 10.1093.
    PubMed     Text format     Abstract available


  111. NEUZIL KM, Fitzpatrick MC
    The Impact of Influenza Vaccine: It's the Size of the Glass.
    Clin Infect Dis. 2019 Feb 2. pii: 5306034. doi: 10.1093.
    PubMed     Text format    


  112. KOREM M, Orenbuch-Harroch E, Ben-Chetrit E, Israel S, et al
    Intensive care admissions and associated severity of influenza B versus A during influenza B-vaccine mismatched seasons.
    Clin Infect Dis. 2019 Feb 1. pii: 5305596. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2019
  113. HASSO-AGOPSOWICZ M, Ladva CN, Lopman B, Sanderson C, et al
    Global review of the age distribution of rotavirus disease in children aged <5 years before the introduction of rotavirus vaccination.
    Clin Infect Dis. 2019 Jan 28. pii: 5303786. doi: 10.1093.
    PubMed     Text format     Abstract available


  114. DIALLO A, Diop OM, Diop D, Niang MN, et al
    Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial.
    Clin Infect Dis. 2019 Jan 28. pii: 5303780. doi: 10.1093.
    PubMed     Text format     Abstract available


  115. GREENWOOD B
    Sustaining Protection Against Epidemic Meningitis in Africa After Vaccination.
    Clin Infect Dis. 2019;68:444-445.
    PubMed     Text format    


  116. MORDMULLER B, Sulyok M, Egger-Adam D, Resende M, et al
    First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria.
    Clin Infect Dis. 2019 Jan 10. pii: 5281109. doi: 10.1093/cid/ciy1140.
    PubMed     Text format     Abstract available


  117. VEKEMANS J, Gouvea-Reis F, Kim JH, Excler JL, et al
    The path to group A Streptococcus vaccines: WHO research and development technology roadmap and preferred product characteristics.
    Clin Infect Dis. 2019 Jan 8. pii: 5280612. doi: 10.1093/cid/ciy1143.
    PubMed     Text format     Abstract available


  118. ASNER SA, Agyeman PKA, Gradoux E, Posfay-Barbe KM, et al
    Burden of Streptococcus pneumoniae sepsis in children after introduction of pneumococcal conjugate vaccines - a prospective population-based cohort study.
    Clin Infect Dis. 2019 Jan 2. pii: 5270128. doi: 10.1093/cid/ciy1139.
    PubMed     Text format     Abstract available


    December 2018
  119. HARDER T, Siedler A
    Systematic review and meta-analysis of chickenpox vaccination and risk of herpes zoster: a quantitative view on the "exogenous boosting hypothesis".
    Clin Infect Dis. 2018 Dec 24. pii: 5258112. doi: 10.1093/cid/ciy1099.
    PubMed     Text format     Abstract available


  120. MUJURU HA, Burnett E, Nathoo KJ, Ticklay I, et al
    Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe.
    Clin Infect Dis. 2018 Dec 23. pii: 5258061. doi: 10.1093/cid/ciy1096.
    PubMed     Text format     Abstract available


  121. MEHANNA H, Bryant TS, Babrah J, Louie K, et al
    Human papillomavirus (HPV) vaccine effectiveness and potential herd immunity for reducing oncogenic oropharyngeal HPV16 prevalence in the UK; a cross-sectional study.
    Clin Infect Dis. 2018 Dec 22. pii: 5257796. doi: 10.1093/cid/ciy1081.
    PubMed     Text format     Abstract available


  122. SOENTJENS P, De Koninck K, Tsoumanis A, Herssens N, et al
    A Comparative Immunogenicity and Safety Trial of Two Different Schedules of Single-visit Intradermal Rabies Post-exposure Vaccination Following a Single-visit Pre-exposure Vaccination.
    Clin Infect Dis. 2018 Dec 19. pii: 5253211. doi: 10.1093.
    PubMed     Text format     Abstract available


  123. DEJON-AGOBE JC, Ateba-Ngoa U, Lalremruata A, Homoet A, et al
    Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2.
    Clin Infect Dis. 2018 Dec 18. pii: 5252072. doi: 10.1093/cid/ciy1087.
    PubMed     Text format     Abstract available


  124. POLLOCK L, Bennett A, Jere KC, Dube Q, et al
    Non-secretor histo-blood group antigen phenotype is associated with reduced risk of clinical rotavirus vaccine failure in Malawian infants.
    Clin Infect Dis. 2018 Dec 18. pii: 5252030. doi: 10.1093/cid/ciy1067.
    PubMed     Text format     Abstract available


  125. FERDINANDS JM, Patel MM, Foppa IM, Fry AM, et al
    Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2018 Dec 18. pii: 5251717. doi: 10.1093/cid/ciy1084.
    PubMed     Text format    


  126. CHEN H, Alvarez JJS, Ng SH, Nielsen R, et al
    Passage adaptation correlates with the reduced efficacy of the influenza vaccine.
    Clin Infect Dis. 2018 Dec 18. pii: 5252062. doi: 10.1093/cid/ciy1065.
    PubMed     Text format     Abstract available


  127. SEMCHENKO EA, Tan A, Borrow R, Seib KL, et al
    The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae.
    Clin Infect Dis. 2018 Dec 14. pii: 5247042. doi: 10.1093/cid/ciy1061.
    PubMed     Text format     Abstract available


  128. NICHOLS MK, Andrew MK, Ye L, Hatchette TF, et al
    The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness (VE) to Prevent Influenza-Related Hospitalizations over Four Influenza Seasons in Canada.
    Clin Infect Dis. 2018 Dec 3. pii: 5228721. doi: 10.1093/cid/ciy1009.
    PubMed     Text format     Abstract available


    November 2018
  129. HARPAZ R, Leung JW
    The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Children.
    Clin Infect Dis. 2018 Nov 29. pii: 5213086. doi: 10.1093.
    PubMed     Text format     Abstract available


  130. HARPAZ R, Leung JW
    The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults.
    Clin Infect Dis. 2018 Nov 29. pii: 5213085. doi: 10.1093.
    PubMed     Text format     Abstract available


  131. BRICKLEY EB, Wright PF, Khalenkov A, Neuzil KM, et al
    The effect of pre-existing immunity on virus detection and immune responses in a phase II randomized trial of a Russian-backbone live attenuated influenza vaccine in Bangladeshi children.
    Clin Infect Dis. 2018 Nov 27. pii: 5210472. doi: 10.1093/cid/ciy1004.
    PubMed     Text format     Abstract available


  132. LEWIS KDC, Ortiz JR, Rahman MZ, Levine MZ, et al
    Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh.
    Clin Infect Dis. 2018 Nov 27. pii: 5210460. doi: 10.1093/cid/ciy1003.
    PubMed     Text format     Abstract available


  133. MCHUGH L, Marshall HS, Perrett KP, Nolan T, et al
    The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study.
    Clin Infect Dis. 2018 Nov 23. pii: 5202330. doi: 10.1093.
    PubMed     Text format     Abstract available


  134. KOLDITZ M, Schmitt J, Pletz MW, Tesch F, et al
    Impact of the 13-valent pneumococcal conjugate vaccine on incidence of all-cause pneumonia in adults aged >/= 60 years - a population-based retrospective cohort study.
    Clin Infect Dis. 2018 Nov 21. pii: 5194155. doi: 10.1093.
    PubMed     Text format     Abstract available


  135. LOEVINSOHN G, Rosman L, Moss WJ
    Measles Seroprevalence and Vaccine Responses in HIV-Infected Adolescents and Adults: A Systematic Review.
    Clin Infect Dis. 2018 Nov 17. pii: 5188002. doi: 10.1093.
    PubMed     Text format     Abstract available


  136. MUTSAERTS EAML, Nunes MC, van Rijswijk MN, Klipstein-Grobusch K, et al
    Measles immunity at 4.5 years of age following vaccination at 9 and 15-18 months of age among HIV-infected, HIV-exposed-uninfected and HIV-unexposed children.
    Clin Infect Dis. 2018 Nov 12. pii: 5174340. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2018
  137. ALTAMIRANO J, Purington N, Behl R, Sarnquist C, et al
    Characterization of Household and Community Shedding and Transmission of Oral Polio Vaccine in Mexican Communities With Varying Vaccination Coverage.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  138. GAENSBAUER JT, Gast C, Bandyopadhyay AS, O'Ryan M, et al
    Impact of Maternal Antibody on the Immunogenicity of Inactivated Polio Vaccine in Infants Immunized With Bivalent Oral Polio Vaccine: Implications for the Polio Eradication Endgame.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  139. ALTAMIRANO J, Leary S, van Hoorebeke C, Sarnquist C, et al
    Validation of a High-throughput, Multiplex, Real-time Qualitative Polymerase Chain Reaction Assay for the Detection of Sabin Oral Polio Vaccine in Environmental Samples.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  140. VAN HOOREBEKE C, Huang C, Leary S, Holubar M, et al
    Lab Protocol Paper: Use of a High-throughput, Multiplex Reverse-transcription Quantitative Polymerase Chain Reaction Assay for Detection of Sabin Oral Polio Vaccine in Fecal Samples.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  141. BHAUMIK SK, Kulkarni RR, Weldon WC, Silveira ELV, et al
    Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  142. JARVIS CI, Altamirano J, Sarnquist C, Edmunds WJ, et al
    Spatial Analyses of Oral Polio Vaccine Transmission in an Community Vaccinated With Inactivated Polio Vaccine.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  143. RESIK S, Tejeda A, Mach O, Fonseca M, et al
    Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  144. FU R, Altamirano J, Sarnquist CC, Maldonado YA, et al
    Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  145. BRICKLEY EB, Wieland-Alter W, Connor RI, Ackerman ME, et al
    Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine-only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chil
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  146. ALTAMIRANO J, Sarnquist C, Behl R, Garcia-Garcia L, et al
    OPV Vaccination and Shedding Patterns in Mexican and US Children.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  147. SARNQUIST C, Holubar M, Garcia-Garcia L, Ferreyra-Reyes L, et al
    Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  148. HALPERN MS, Altamirano J, Maldonado Y
    Pediatric HIV Infection and Decreased Prevalence of OPV Point Mutations Linked to Vaccine-associated Paralytic Poliomyelitis.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  149. BANDYOPADHYAY AS, Modlin JF, Wenger J, Gast C, et al
    Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
    Clin Infect Dis. 2018;67.
    PubMed     Text format     Abstract available


  150. DANINO D, Givon-Lavi N, Ben-Shimol S, Greenberg D, et al
    Understanding the evolution of antibiotic-nonsusceptible pneumococcal nasopharyngeal colonization following pneumococcal conjugate vaccines implementation in young children.
    Clin Infect Dis. 2018 Oct 29. pii: 5146358. doi: 10.1093.
    PubMed     Text format     Abstract available


  151. HAVERS FP, Chung JR, Belongia EA, McLean HQ, et al
    Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011-2017.
    Clin Infect Dis. 2018 Oct 27. pii: 5145968. doi: 10.1093.
    PubMed     Text format     Abstract available


  152. SINGS HL, De Wals P, Gessner BD, Isturiz R, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-Analysis of Observational Studies.
    Clin Infect Dis. 2018 Oct 23. pii: 5142858. doi: 10.1093.
    PubMed     Text format     Abstract available


  153. LOPEZ BERNAL JA, Andrews N, Amirthalingam G
    The use of quasi-experimental designs for vaccine evaluation.
    Clin Infect Dis. 2018 Oct 22. pii: 5140188. doi: 10.1093.
    PubMed     Text format     Abstract available


  154. PRAHARAJ I, Platts-Mills JA, Taneja S, Antony K, et al
    Diarrheal etiology and impact of co-infections on rotavirus vaccine efficacy estimates in a clinical trial of a monovalent human-bovine (116E) oral rotavirus vaccine, Rotavac, India.
    Clin Infect Dis. 2018 Oct 17. pii: 5134205. doi: 10.1093.
    PubMed     Text format     Abstract available


  155. SMITS G, Stabell Benn C, Whittle H, van Binnendijk R, et al
    Maternal measles antibodies and their influence on all-cause mortality following measles vaccination: an alternative to measure very low maternal antibody levels.
    Clin Infect Dis. 2018 Oct 16. pii: 5133427. doi: 10.1093.
    PubMed     Text format     Abstract available


  156. WEINBERGER DM, Shapiro ED
    Prevention of Pneumococcal Infections in Adults using Conjugate Vaccines: No Easy Answers.
    Clin Infect Dis. 2018 Oct 12. pii: 5127383. doi: 10.1093.
    PubMed     Text format    


  157. VADLAMUDI NK, Chen A, Marra F
    Impact of 13-pneumococcal conjugate vaccine among adults: a systematic review and meta-analysis.
    Clin Infect Dis. 2018 Oct 12. pii: 5127380. doi: 10.1093.
    PubMed     Text format     Abstract available


  158. HYLE EP, Fields NF, Fiebelkorn AP, Walker AT, et al
    The Clinical Impact and Cost-effectiveness of MMR Vaccination to Prevent Measles Importations among US International Travelers.
    Clin Infect Dis. 2018 Oct 11. pii: 5127132. doi: 10.1093.
    PubMed     Text format     Abstract available


  159. SKOWRONSKI DM, Chambers C, De Serres G, Sabaiduc S, et al
    Vaccine effectiveness against lineage matched and mismatched influenza B viruses across 8 seasons in Canada, 2010-11 to 2017-18.
    Clin Infect Dis. 2018 Oct 11. pii: 5127119. doi: 10.1093.
    PubMed     Text format     Abstract available


  160. THOMPSON MG, Kwong JC, Regan AK, Katz MA, et al
    Influenza Vaccine Effectiveness in Preventing Influenza-associated Hospitalizations During Pregnancy: A Multi-country Retrospective Test Negative Design Study, 2010-2016.
    Clin Infect Dis. 2018 Oct 11. pii: 5126390. doi: 10.1093.
    PubMed     Text format     Abstract available


  161. MUNOZ FM
    Influenza Vaccination During Pregnancy Can Protect Women Against Hospitalization Across Continents.
    Clin Infect Dis. 2018 Oct 11. pii: 5126392. doi: 10.1093.
    PubMed     Text format    


  162. HILLIER SL, Ferrieri P, Edwards MS, Ewell M, et al
    A Phase II Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide -Tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization with GBS III.
    Clin Infect Dis. 2018 Oct 3. pii: 5114388. doi: 10.1093.
    PubMed     Text format     Abstract available


  163. YOUNG B, Sadarangani S, Sen Yew H, Yung CF, et al
    Six-monthly versus annual influenza vaccination in older adults in the tropics: an observer-blind, active-comparator controlled, randomised superiority trial.
    Clin Infect Dis. 2018 Oct 1. pii: 5113434. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  164. WANG W, Chen Q, Ford-Siltz LA, Katzelnick LC, et al
    Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains after Vaccination with Inactivated Trivalent Influenza Vaccine Vary with Age and Prior Year Vaccination.
    Clin Infect Dis. 2018 Sep 25. pii: 5106972. doi: 10.1093.
    PubMed     Text format     Abstract available


  165. GIBANI MM, Voysey M, Jin C, Jones C, et al
    The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies.
    Clin Infect Dis. 2018 Sep 25. pii: 5106547. doi: 10.1093.
    PubMed     Text format     Abstract available


  166. LEE RU, Phillips CJ, Faix DJ
    Seasonal Influenza Vaccine Impact on Pandemic H1N1 Vaccine Efficacy.
    Clin Infect Dis. 2018 Sep 20. pii: 5104116. doi: 10.1093.
    PubMed     Text format     Abstract available


  167. PINANA JL, Perez A, Montoro J, Gimenez E, et al
    Clinical effectiveness of influenza vaccination after allogeneic hematopoietic stem cell transplantation: A cross-sectional prospective observational study.
    Clin Infect Dis. 2018 Sep 15. pii: 5098399. doi: 10.1093.
    PubMed     Text format     Abstract available


  168. FLANNERY B, Chung JR, Monto AS, Martin ET, et al
    Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season.
    Clin Infect Dis. 2018 Sep 11. pii: 5094815. doi: 10.1093.
    PubMed     Text format     Abstract available


  169. RAY GT, Lewis N, Klein NP, Daley MF, et al
    Intra-season Waning of Influenza Vaccine Effectiveness.
    Clin Infect Dis. 2018 Sep 10. pii: 5094689. doi: 10.1093.
    PubMed     Text format     Abstract available


  170. LIPSITCH M
    Challenges of vaccine effectiveness and waning studies.
    Clin Infect Dis. 2018 Sep 10. pii: 5094713. doi: 10.1093.
    PubMed     Text format    


  171. CHEN LH, Kozarsky PE, Visser LG
    What's old is new again: the re-emergence of yellow fever in Brazil and vaccine shortages.
    Clin Infect Dis. 2018 Sep 10. pii: 5094712. doi: 10.1093.
    PubMed     Text format     Abstract available


  172. COWLING BJ, Lim WW, Perera RAPM, Fang VJ, et al
    Influenza hemagglutination-inhibition antibody titer as a mediator of vaccine-induced protection for influenza B.
    Clin Infect Dis. 2018 Sep 8. pii: 5092748. doi: 10.1093.
    PubMed     Text format     Abstract available


  173. POMAT WS, van den Biggelaar AHJ, Wana S, Greenhill AR, et al
    Safety and immunogenicity of pneumococcal conjugate vaccines in a high-risk population: a randomised controlled trial of 10-valent and 13-valent PCV in Papua New Guinean infants.
    Clin Infect Dis. 2018 Sep 3. pii: 5089945. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  174. USUF E, Bottomley C, Bojang E, Cox I, et al
    Persistence of nasopharyngeal pneumococcal vaccine serotypes and increase of non-vaccine serotypes among vaccinated infants and their mothers five years after PCV13 introduction in The Gambia.
    Clin Infect Dis. 2018 Aug 24. pii: 5079135. doi: 10.1093.
    PubMed     Text format     Abstract available


  175. BLYTH CC, Macartney KK, McRae J, Clark JE, et al
    Influenza Epidemiology, Vaccine Coverage and Vaccine Effectiveness in Children Admitted to Sentinel Australian Hospitals in 2017: Results from the PAEDS-FluCAN Collaboration.
    Clin Infect Dis. 2018 Aug 21. pii: 5077025. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  176. YARO S, Njanpop Lafourcade BM, Ouangraoua S, Ouoba A, et al
    Antibody Persistence at the Population Level 5 Years After Mass Vaccination With Meningococcal Serogroup A Conjugate Vaccine (PsA-TT) in Burkina Faso: Need for a Booster Campaign?
    Clin Infect Dis. 2018 Jul 26. pii: 5059984. doi: 10.1093.
    PubMed     Text format     Abstract available


  177. BLANCHARD ROHNER G, Chatzis O, Chinwangso P, Rohr M, et al
    Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
    Clin Infect Dis. 2018 Jul 26. pii: 5059783. doi: 10.1093.
    PubMed     Text format     Abstract available


  178. PETOUSIS-HARRIS H, Howe AS, Janine P, Turner N, et al
    Pneumococcal conjugate vaccines turning the tide on inequity - a retrospective cohort study of New Zealand children born 2006-2015.
    Clin Infect Dis. 2018 Jul 19. pii: 5055833. doi: 10.1093.
    PubMed     Text format     Abstract available


  179. BAKER JM, Tate JE, Steiner CA, Haber MJ, et al
    Longer-term direct and indirect effects of infant rotavirus vaccination across all ages in the US; 2000 - 2013: analysis of a large hospital discharge dataset.
    Clin Infect Dis. 2018 Jul 18. pii: 5055445. doi: 10.1093.
    PubMed     Text format     Abstract available


  180. HALPERIN SA, Langley JM, Ye L, MacKinnon-Cameron D, et al
    A Randomized Controlled Trial of the Safety and Immunogenicity of Tetanus, Diphtheria, and Acellular Pertussis Vaccine Immunization During Pregnancy and Subsequent Infant Immune Response.
    Clin Infect Dis. 2018 Jul 13. pii: 5053576. doi: 10.1093.
    PubMed     Text format     Abstract available


  181. XU Y, Ye J
    Predicting influenza vaccine effectiveness with hemagglutinin sequences is not sufficient enough.
    Clin Infect Dis. 2018 Jul 9. pii: 5050680. doi: 10.1093.
    PubMed     Text format    


  182. MCCLYMONT E, Lee M, Raboud J, Coutlee F, et al
    The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living with HIV.
    Clin Infect Dis. 2018 Jul 7. pii: 5050411. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  183. STEINER-MONARD V, Kamaka K, Karoui O, Roethlisberger S, et al
    The Candidate Blood Stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase I Trial in Exposed and Non Exposed Volunteers.
    Clin Infect Dis. 2018 Jun 26. pii: 5045203. doi: 10.1093.
    PubMed     Text format     Abstract available


  184. SOENTJENS P, Andries P, Aerssens A, Tsoumanis A, et al
    Pre-exposure intradermal rabies vaccination: a non-inferiority trial in healthy adults on shortening the vaccination schedule from 28 to 7 days.
    Clin Infect Dis. 2018 Jun 25. pii: 5043520. doi: 10.1093.
    PubMed     Text format     Abstract available


  185. TRIEU MC, Jul-Larsen A, Saevik M, Madsen A, et al
    Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: a five-year follow-up study.
    Clin Infect Dis. 2018 Jun 9. pii: 5035295. doi: 10.1093.
    PubMed     Text format     Abstract available


  186. CHERRY JD, Zahn M
    Clinical Characteristics of Measles in Previously Vaccinated and Unvaccinated Patients in California.
    Clin Infect Dis. 2018 Jun 7. pii: 5034094. doi: 10.1093.
    PubMed     Text format     Abstract available


  187. MOSS W
    Measles in Vaccinated Individuals and the Future of Measles Elimination.
    Clin Infect Dis. 2018 Jun 7. pii: 5034071. doi: 10.1093.
    PubMed     Text format    


  188. KILMER GA, Barker LK, Ly KN, Jiles RB, et al
    Hepatitis B vaccination and screening among foreign-born women of reproductive age in the United States: 2013-2015.
    Clin Infect Dis. 2018 Jun 1. pii: 5026244. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  189. SORUP S, Jensen AKG, Aaby P, Benn CS, et al
    Revaccination with Measles-mumps-rubella Vaccine and Infectious Disease Morbidity: A Danish Register-based Cohort Study.
    Clin Infect Dis. 2018 May 26. pii: 5005938. doi: 10.1093.
    PubMed     Text format     Abstract available


  190. MCLAUGHLIN JM, Jiang Q, Isturiz RE, Sings HL, et al
    Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design.
    Clin Infect Dis. 2018 May 21. pii: 5000157. doi: 10.1093.
    PubMed     Text format     Abstract available


  191. BURKE RM, Tate JE, Dahl RM, Aliabadi N, et al
    Rotavirus Vaccination Is Associated with Reduced Seizure Hospitalization Risk Among Commercially Insured U.S. Children.
    Clin Infect Dis. 2018 May 16. pii: 4996816. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  192. CASADEVALL A, Pirofski LA
    A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis.
    Clin Infect Dis. 2018 Apr 25. pii: 4984538. doi: 10.1093.
    PubMed     Text format    


  193. EDWARDS JE JR, Schwartz MM, Schmidt CS, Sobel JD, et al
    A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial.
    Clin Infect Dis. 2018 Apr 25. pii: 4984537. doi: 10.1093.
    PubMed     Text format     Abstract available


  194. SKOWRONSKI DM, De Serres G
    Role of egg-adaptation mutations in low influenza A(H3N2) vaccine effectiveness during the 2012-13 season.
    Clin Infect Dis. 2018 Apr 24. pii: 4983050. doi: 10.1093.
    PubMed     Text format    


  195. KOSIKOVA M, Li L, Radvak P, Ye Z, et al
    Imprinting of Repeated Influenza A/H3 Exposures on Antibody Quantity and Antibody Quality: Implications on Seasonal Vaccine Strain Selection and Vaccine Performance.
    Clin Infect Dis. 2018 Apr 17. pii: 4972882. doi: 10.1093.
    PubMed     Text format     Abstract available


  196. BONOMO ME, Deem MW
    Predicting Influenza H3N2 Vaccine Efficacy from Evolution of the Dominant Epitope.
    Clin Infect Dis. 2018 Apr 17. pii: 4972858. doi: 10.1093.
    PubMed     Text format     Abstract available


  197. WILKIN TJ, Chen H, Cespedes MS, Leon-Cruz JT, et al
    A randomized, placebo-controlled trial of the quadrivalent HPV vaccine in HIV-infected adults age 27 years or older: AIDS Clinical Trials Group protocol A5298.
    Clin Infect Dis. 2018 Apr 5. pii: 4961357. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  198. SIGURETHSSON S, Eythorsson E, Hrafnkelsson B, Erlendsdottir H, et al
    Reduction in all-cause acute otitis media in children less than three years of age in primary care following pneumococcal vaccination with PHiD-CV10: A whole population study.
    Clin Infect Dis. 2018 Mar 30. pii: 4956759. doi: 10.1093.
    PubMed     Text format     Abstract available


  199. HANSON KE, Koch B, Bonner K, McRee AL, et al
    National Trends in Parental HPV Vaccination Intentions and Reasons for Hesitancy, 2010-2015.
    Clin Infect Dis. 2018 Mar 27. pii: 4955216. doi: 10.1093.
    PubMed     Text format     Abstract available


  200. BENSON CA, Andersen JW, Macatangay BJC, Mailliard RB, et al
    Safety and Immunogenicity of Zoster Vaccine Live in HIV-Infected Adults with CD4+ Cell Counts Above 200 Cells/mL Virologically Suppressed on Antiretroviral Therapy.
    Clin Infect Dis. 2018 Mar 26. pii: 4953774. doi: 10.1093.
    PubMed     Text format     Abstract available


  201. DE SERRES G, Skowronski DM
    Ecological Fallacy, Nonspecific Outcomes, and the Attribution of Disproportionate Vaccine Benefits.
    Clin Infect Dis. 2018 Mar 21. pii: 4948704. doi: 10.1093.
    PubMed     Text format    


  202. SAITO N, Komori K, Suzuki M, Kishikawa T, et al
    Dose-Dependent Negative Effects of Prior Multiple Vaccinations against Influenza A and Influenza B among School Children: A Study of Kamigoto Island in Japan during the 2011/12, 2012/13 and 2013/14 Influenza Seasons.
    Clin Infect Dis. 2018 Mar 8. pii: 4924693. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  203. COBEY S, Gouma S, Parkhouse K, Chambers BS, et al
    Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13.
    Clin Infect Dis. 2018 Feb 20. pii: 4846904. doi: 10.1093.
    PubMed     Text format     Abstract available


  204. ANDERSON EJ, Daugherty MA, Pickering LK, Orenstein WA, et al
    Protecting the Community through Child Vaccination.
    Clin Infect Dis. 2018 Feb 17. pii: 4868144. doi: 10.1093.
    PubMed     Text format     Abstract available


  205. JAYASINGHE S, Chiu C, Quinn H, Menzies R, et al
    Effectiveness of Seven and Thirteen Valent Pneumococcal Conjugate Vaccines in a Schedule without a Booster dose: a Ten Year Observational Study.
    Clin Infect Dis. 2018 Feb 17. pii: 4868133. doi: 10.1093.
    PubMed     Text format     Abstract available



  206. Philippines Says Anti-Dengue Vaccine may be Connected to Three Deaths.
    Clin Infect Dis. 2018 Feb 17. pii: 4868143. doi: 10.1093.
    PubMed     Text format    


  207. WHITNEY CG
    Examining Duration of Protection: should a Booster dose be Part of all Infant Pneumococcal Conjugate Vaccine Programs?
    Clin Infect Dis. 2018 Feb 17. pii: 4868134. doi: 10.1093.
    PubMed     Text format    


  208. KATZ J, Englund JA, Steinhoff MC, Khatry SK, et al
    Impact of timing of influenza vaccination in pregnancy on transplacental antibody transfer, influenza incidence and birth outcomes; a randomized trial in rural Nepal.
    Clin Infect Dis. 2018 Feb 14. pii: 4857181. doi: 10.1093.
    PubMed     Text format     Abstract available


  209. IZURIETA HS, Chillarige Y, Kelman JA, Forshee R, et al
    Statin use and risks of influenza-related outcomes among older adults receiving standard-dose or high-dose influenza vaccines through Medicare during 2010-2015.
    Clin Infect Dis. 2018 Feb 9. pii: 4846330. doi: 10.1093.
    PubMed     Text format     Abstract available


  210. SUZUKI M, Saito N
    Influenza vaccine effectiveness and age.
    Clin Infect Dis. 2018 Feb 7. pii: 4841718. doi: 10.1093.
    PubMed     Text format    


    January 2018
  211. VOYSEY M, Pollard AJ
    Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV).
    Clin Infect Dis. 2018 Jan 17. pii: 4815743. doi: 10.1093/cid/cix1145.
    PubMed     Text format     Abstract available


  212. BURGNER DP, Miller JE, Strunk T, Nassar N, et al
    Growth Parameters, Effect Measure Modification and the Association Between Vaccination and Early Childhood Hospitalization With Non-targeted Infections.
    Clin Infect Dis. 2018;66:318-319.
    PubMed     Text format    


  213. VAN DEURSEN AMM, van Houten MA, Webber C, Patton M, et al
    The impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study.
    Clin Infect Dis. 2018 Jan 6. pii: 4792029. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  214. SIMMONS G, Stone M, Busch MP
    Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics.
    Clin Infect Dis. 2017 Dec 30. pii: 4760439. doi: 10.1093.
    PubMed     Text format    


  215. PLENNEVAUX E, Moureau A, Arredondo-Garcia JL, Villar L, et al
    Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials.
    Clin Infect Dis. 2017 Dec 30. pii: 4782289. doi: 10.1093.
    PubMed     Text format     Abstract available


  216. CHONG PP, Handler L, Weber DJ
    A Systematic Review of Safety and Immunogenicity of Influenza Vaccination Strategies in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2017 Dec 14. pii: 4743238. doi: 10.1093/cid/cix1081.
    PubMed     Text format     Abstract available


  217. NATORI Y, Shiotsuka M, Slomovic J, Hoschler K, et al
    A Double Blind Randomized Trial of High Dose vs. Standard Dose Influenza Vaccine in Adult Solid Organ Transplant Recipients.
    Clin Infect Dis. 2017 Dec 14. pii: 4743251. doi: 10.1093/cid/cix1082.
    PubMed     Text format     Abstract available


    November 2017
  218. LOPEZ AL, Deen J, Azman AS, Luquero FJ, et al
    Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and meta-analysis.
    Clin Infect Dis. 2017 Nov 21. pii: 4645296. doi: 10.1093/cid/cix1039.
    PubMed     Text format     Abstract available


  219. FISKER AB, Nebie E, Schoeps A, Martins C, et al
    A two-centre randomised trial of an additional early dose of measles vaccine: Effects on mortality and measles antibody levels.
    Clin Infect Dis. 2017 Nov 21. pii: 4645294. doi: 10.1093/cid/cix1033.
    PubMed     Text format     Abstract available


  220. YE S, Whiley DM, Ware RS, Kirkwood CD, et al
    Multivalent rotavirus vaccine and wild-type rotavirus strain shedding in Australian infants: a birth cohort study.
    Clin Infect Dis. 2017 Nov 15. doi: 10.1093/cid/cix1022.
    PubMed     Text format     Abstract available


  221. STEIN Y, Mandelboim M, Sefty H, Pando R, et al
    Seasonal influenza vaccine effectiveness in preventing laboratory-confirmed influenza in primary care in Israel 2016-2017 season: insights into novel age-specific analysis.
    Clin Infect Dis. 2017 Nov 14. doi: 10.1093/cid/cix1013.
    PubMed     Text format     Abstract available


  222. VEIT O, Domingo C, Niedrig M, Staehelin C, et al
    Long-term immune response to yellow fever vaccination in HIV-infected individuals depends on HIV-RNA suppression status: Implications for vaccination schedule.
    Clin Infect Dis. 2017 Nov 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  223. LAWN JE, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, et al
    Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?
    Clin Infect Dis. 2017;65.
    PubMed     Text format     Abstract available


    October 2017
  224. FATHIMA P, Blyth CC, Lehmann D, Lim FJ, et al
    The impact of pneumococcal vaccination on bacterial and viral pneumonia in Western Australian children: record linkage cohort study of 469,589 births (1996-2012).
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  225. TAM YH, Valkenburg SA, Perera RAPM, Wong JHF, et al
    Immune responses to twice-annual influenza vaccination in older adults in Hong Kong.
    Clin Infect Dis. 2017 Oct 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  226. POEHLING KA, Caspard H, Peters TR, Belongia EA, et al
    2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  227. ORTIZ JR
    The challenge of vaccine policy-making with imperfect data.
    Clin Infect Dis. 2017 Oct 4. doi: 10.1093.
    PubMed     Text format    


  228. KJAER SK, Nygard M, Dillner J, Brooke Marshall J, et al
    A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.
    Clin Infect Dis. 2017 Oct 1. doi: 10.1093.
    PubMed     Text format     Abstract available


  229. EBERHARDSON M, Hall S, Papp KA, Sterling TM, et al
    Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Clin Infect Dis. 2017;65:1174-1182.
    PubMed     Text format     Abstract available


  230. OLIGBU G, Collins S, Andrews N, Sheppard CL, et al
    Characteristics and Serotype Distribution of Childhood Cases of Invasive Pneumococcal Disease Following Pneumococcal Conjugate Vaccination in England and Wales, 2006-2014.
    Clin Infect Dis. 2017;65:1191-1198.
    PubMed     Text format     Abstract available


    September 2017
  231. SKOFF TH, Blain AE, Watt J, Scherzinger K, et al
    Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.
    Clin Infect Dis. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  232. LUCA DL, Kwong JC, Chu A, Sander B, et al
    Impact of Pneumococcal Vaccination on Pneumonia Hospitalizations and Related Costs in Ontario: A Population-Based Ecological Study.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  233. NEMES E, Hesseling AC, Tameris M, Mauff K, et al
    Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial.
    Clin Infect Dis. 2017 Sep 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  234. MADHI SA, Koen A, Cutland CL, Jose L, et al
    Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  235. ARCIUOLO RJ, Jablonski RR, Zucker JR, Rosen JB, et al
    Effectiveness of Measles Vaccination and Immune Globulin Post-Exposure Prophylaxis in an Outbreak Setting-New York City, 2013.
    Clin Infect Dis. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  236. SCHROEDER MR, Chancey ST, Thomas S, Kuo WH, et al
    A Population-Based Assessment of the Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines on Macrolide-Resistant Invasive Pneumococcal Disease: Emergence and Decline of Streptococcus pneumoniae Serotype 19A (CC320) With Dual Macrolide Resistance
    Clin Infect Dis. 2017;65:990-998.
    PubMed     Text format     Abstract available


  237. KIM L, Rha B, Abramson JS, Anderson LJ, et al
    Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines.
    Clin Infect Dis. 2017;65:1020-1025.
    PubMed     Text format     Abstract available


  238. PIROTH L, Launay O, Miailhes P, Carrat F, et al
    Isolated anti-HBc serological profile: has the time come to vaccinate?
    Clin Infect Dis. 2017 Sep 15. doi: 10.1093.
    PubMed     Text format    


  239. MCNAMARA LA, Skoff T, Faulkner A, Miller L, et al
    Reduced Severity of Pertussis in Persons With Age-Appropriate Pertussis Vaccination-United States, 2010-2012.
    Clin Infect Dis. 2017;65:811-818.
    PubMed     Text format     Abstract available


  240. VAN DEURSEN AMM, van Houten MA, Webber C, Patton M, et al
    Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
    Clin Infect Dis. 2017;65:787-795.
    PubMed     Text format     Abstract available


  241. PILLSBURY AJ, Quinn HE, Evans TD, McIntyre PB, et al
    Population-Level Herd Protection of Males From a Female Human Papillomavirus Vaccination Program: Evidence from Australian Serosurveillance.
    Clin Infect Dis. 2017;65:827-832.
    PubMed     Text format     Abstract available


    August 2017
  242. YANG Y, Meng Y, Halloran ME, Longini IM Jr, et al
    Dependency of Vaccine Efficacy on Pre-Exposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  243. LEE YJ, Huang YT, Kim SJ, Kerpelev M, et al
    Trends in invasive pneumococcal disease (IPD) in cancer patients after the introduction of 7-valent pneumococcal conjugate vaccine (PCV7): A 20-year longitudinal study at a major urban cancer center.
    Clin Infect Dis. 2017 Aug 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  244. SHAH M, Quinlisk P, Weigel A, Riley J, et al
    Mumps outbreak in a highly vaccinated university-affiliated setting before and after a measles-mumps-rubella (MMR) vaccination campaign-Iowa, July 2015-May 2016.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  245. HEATH G, Depledge DP, Brown JR, Hale AD, et al
    Acute Retinal Necrosis caused by the zoster vaccine virus.
    Clin Infect Dis. 2017 Aug 2. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  246. LEWNARD JA, Givon-Lavi N, Weinberger DM, Lipsitch M, et al
    Pan-serotype reduction in progression of Streptococcus pneumoniae to otitis media after rollout of pneumococcal conjugate vaccines.
    Clin Infect Dis. 2017 Jul 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  247. WARREN JL, Shioda K, Kurum E, Schuck-Paim C, et al
    Impact of Pneumococcal Conjugate Vaccines on Pneumonia Hospitalizations in High- and Low-Income Subpopulations in Brazil.
    Clin Infect Dis. 2017 Jul 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  248. PETRIE JG, Malosh RE, Cheng CK, Ohmit SE, et al
    The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine.
    Clin Infect Dis. 2017 Jul 20. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  249. ZUCMAN D, Farfour E, Mazaux L, Hillaire S, et al
    How to face the outbreak of viral hepatitis A in men-who-have-sex-with-men in France without vaccines?
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format    


  250. DE WALS P, Deceuninck G, Lefebvre B, Tsang R, et al
    Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
    Clin Infect Dis. 2017;64:1263-1267.
    PubMed     Text format     Abstract available


    December 2016
  251. LARSON HJ
    Japanese media and the HPV vaccine saga.
    Clin Infect Dis. 2016.
    PubMed     Text format    


  252. GILL CJ, Mwananyanda L, MacLeod W, Kwenda G, et al
    Incidence of Severe and Nonsevere Pertussis Among HIV-Exposed and -Unexposed Zambian Infants Through 14 Weeks of Age: Results From the Southern Africa Mother Infant Pertussis Study (SAMIPS), a Longitudinal Birth Cohort Study.
    Clin Infect Dis. 2016;63.
    PubMed     Text format     Abstract available


    June 2016
  253. TRAN TT
    Hepatitis B in Pregnancy.
    Clin Infect Dis. 2016;62 Suppl 4:S314-7.
    PubMed     Text format     Abstract available


  254. SHANKAR H, Blanas D, Bichoupan K, Ndiaye D, et al
    A Novel Collaborative Community-Based Hepatitis B Screening and Linkage to Care Program for African Immigrants.
    Clin Infect Dis. 2016;62 Suppl 4:S289-97.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: